Swiss Life Holding


Solid H1 20 figures, all targets confirmed despite COVID-19

13/08/20 -"• Net profit attributable to shareholders decreased by 13% to CHF533m for H1 20 • Gross written premiums were down by 17% for H1 20 due to a special Swiss effect in 2019 but +2% on an adjusted ..."

Pages
51
Language
English
Published on
13/08/20
You may also be interested by these reports :
18/12/25
Storebrand has presented a convincing strategic plan at its CMD. While the group’s growth drivers are expected to remain broadly unchanged, we were ...

17/12/25
Uniqa’s recent CME conveyed a strong sense of optimism, and rightly so in our view. Beyond the formal upgrade of the FY28 targets, the key takeaways ...

17/12/25
Following Uniqa’s Capital Markets Event, we have reviewed our assumptions and are revising our SOTP valuation upwards. This reflects not only our ...

11/12/25
We are updating our assumptions on Helvetia Baloise following the publication of pro-forma accounts post-merger. The impacts are substantial on both ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO